Compared to siRNA-EZH2 or cisplatin alone, cisplatin- and siRNA-EZH2-loaded nanoparticles induce more toxicity against cancer cells, showing a synergistic impact capable of reversing chemoresistance [247]. The gene discussed is EZH2; the disease is cancer.